Latest News
FDA accepts Bayer's application for KERENDIA in chronic kidney disease without diabetes
8 October 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) said on Thursday that the US Food and Drug Administration (FDA) has accepted its supplemental New Drug Application for KERENDIA (finerenone) for adults w...
Boehringer Ingelheim announces availability of new Quarterable Snap-Tab design for PREVICOX (firocoxib) Chewable Tablets
8 October 2026 - Pharmaceutical company Boehringer Ingelheim announced on Wednesday the availability of the new Quarterable Snap-Tab design for PREVICOX (firocoxib) Chewable Tablets for dogs, following approval from the US Food and Drug Administratio...
Okami Medical receives FDA approval for expanded indication of LOBO Vascular Occluder
8 October 2026 - Medical technology company Okami Medical announced on Wednesday that it has received approval from the US FDA for an expanded indication of its LOBO Vascular Occlusion System.The expanded indication extends the use of LOBO into perip...
WuXi AppTec awarded EcoVadis gold medal for third year
8 October 2026 - WuXi AppTec, a global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), announced on Wednesday that it has received a gold medal from EcoVadis for the third consecutive year.EcoVadis is a sustaina...
Suzhou Ribo Life Science submits Phase I Clinical Trial Application for RBD3133 in EU
8 October 2026 - China-based biopharmaceutical company Suzhou Ribo Life Science Co Ltd (HK:06938), and its Swedish subsidiary Ribocure Pharmaceuticals AB (collectively referred to as Ribo), announced on Wednesday that they have submitted a Phase I Cl...